Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTCX:US

23.95 USD 0.63 2.56%

As of 09:29:30 ET on 05/05/2015.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTCX)

Year To Date: +9.21% 3-Month: +4.45% 3-Year: +40.47% 52-Week Range: 15.62 - 26.70
1-Month: -3.70% 1-Year: +45.72% 5-Year: +30.92% Beta vs MXWO: 1.09

Mutual Fund Chart for FBTCX

No chart data available.
  • FBTCX:US 23.95
  • 1M
  • 1Y
Interactive FBTCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTCX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTCX

NAV (on 2015-05-05) 23.95
Assets (M) (on 2015-04-30) 3,075.25
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTCX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.52

Fees & Expenses for FBTCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.83

Top Fund Holdings for FBTCX

Filing Date: 03/31/2015
Name Position Value % of Total
Gilead Sciences Inc 2,767,007 271,526,397 8.851%
Biogen Inc 600,137 253,401,847 8.260%
Celgene Corp 1,700,603 196,045,514 6.391%
Alexion Pharmaceuticals Inc 803,137 139,183,642 4.537%
Regeneron Pharmaceuticals Inc 260,071 117,416,855 3.827%
Vertex Pharmaceuticals Inc 973,645 114,860,901 3.744%
BioMarin Pharmaceutical Inc 915,738 114,119,270 3.720%
Receptos Inc 450,142 74,223,914 2.419%
Incyte Corp 807,002 73,969,803 2.411%
Amgen Inc 387,830 61,994,626 2.021%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil